Patients with advanced dementia often develop dysphagia (difficulties swallowing). They also experience changes in appetite and apraxia (difficulty co-coordinating movements) and may have difficulties feeding themselves. Two methods of enteral tube feeding are commonly used: the administration of food and fluids via a nasogastric tube (a tube that is passed through the nose and into the stomach) or via a percutaneous endoscopic gastrostomy (PEG) where a feeding tube is inserted into the stomach and is accessed through a permanent incision in the abdominal wall. The decision to use artificial hydration and nutrition in someone with dementia is often emotive and complex. Relatives and carers may request the intervention because they are concerned that the patient may starve; clinicians may be aware of the risks but feel pressurised by institutional, societal or even legal directives to intervene. We found no conclusive evidence that enteral tube nutrition is effective in terms of prolonging survival, improving quality of life, or leading to better nourishment or decreasing the risk of pressure sores. It may actually increase the risk of developing pneumonia due to inhaling small quantities of the feed and even death. This area is difficult to research but better designed studies are required to provide more robust evidence.
There is insufficient evidence to suggest that enteral tube feeding is beneficial in patients with advanced dementia. Data are lacking on the adverse effects of this intervention
Published Online:
April 15, 2009
Health topics:
More like this
- Insufficient evidence for the efficacy and safety of antidepressants for depression in dementia
- Atypical antipsychotics benefit people with dementia but the risks of adverse events may outweigh the benefits, particularly with long term treatment
- There is no substantial evidence to support nor discourage the use of music therapy in the care of older people with dementia
- No new evidence of the efficacy of validation therapy for people with dementia or cognitive impairment has been identified. The new study identified Schrijnemaekers 2002 was excluded because it was not deemed to be validation therapy.
- Inconclusive evidence of the efficacy of reminiscence therapy for dementia
